SFDA has issued Regulatory Guidance for Submissions and Applications
The Saudi Food and Drug Authority (SFDA) has issued its An important
Regulinked
- October 18, 2026
- Acceleration process
- No Comments
Blog
EDE has issued Pharmacovigilance Practice Guideline for Medical Products
According to Resolution No. (27) of 2026, published by the Emirates Drug
- July 29, 2026
- Acceleration process
- No Comments
SFDA has issued Regulatory Guide for SFDA Services in Duty- and Tax-Suspended Zones
SFDA has issued a new regulatory guide clarifying the services and requirements
- July 28, 2026
- Acceleration process
- No Comments
SFDA published six guidelines regarding classification of violations and associated penalties
SFDA has published six guidelines regarding classification of violations and associated penalties
- July 28, 2026
- Acceleration process
- No Comments
Oman MOH – Circular No. Circular No. 51/2026 – Suspension of Receiving Medicines and Biological Products Registration Files
OMAN MOH issued new Circular No. 51/2026 – Suspension of Receiving Medicines
- May 31, 2026
- Guideline
- No Comments
NHRA updated “Medicine Submission, Renewal & Variations Guidelines”
NHRA has updated three key pharmaceutical regulatory guidelines in Bahrain as part
- May 16, 2026
- Guideline
- No Comments
Oman MOH – Circular No. 45/2026 – Adherence to Procuring Medicines and Health Products from Authorized Agents Only
OMAN MOH issued new Circular No. 45/2026 – Adherence to Procuring Medicines
- April 30, 2026
- Guideline
- No Comments
Remaining Shelf Life Requirement for Imported Medicines – Qatar
Qatar MoPH Issues Circular on Remaining Shelf Life Requirement for Imported Medicines
Regulinked@gmail.com
- April 11, 2026
- Guideline
- No Comments
Oman MOH – Circular No. 35/2026 introducing updated restrictions on the use of Ivy Leaf Extract in herbal medicines
OMAN MOH issued new Circular No. 35/2026 introducing updated restrictions on the
- April 10, 2026
- Guideline
- No Comments
SFDA Issues “Guidelines for Chemical and Pharmaceutical Quality Documentation of Small Molecules Investigational Products in Clinical Trials” (Version 1.0)
Saudi Food and Drug Authority (SFDA) has issued Version 1.0 of new
- March 21, 2026
- Acceleration process
- No Comments
ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.